Innovative Research Award
| Henry Wong |
| Researcher |
Henry Wong |
| Affiliation |
VA San Diego Healthcare System |
| Country |
United States |
| Scopus ID |
55574188738 |
| Documents |
94 |
| Citations |
3,633 |
| h-index |
30 |
| Subject Area |
Biomarkers of response |
| Event |
World Life Science Awards |
The Innovative Research Award recognizes sustained scholarly contributions that advance scientific understanding and improve translational research outcomes. Henry Wong, affiliated with the VA San Diego Healthcare System, has established a publication record within the field of biomarkers of response, supported by a substantial body of peer-reviewed research indexed in Scopus. The available bibliometric indicators, including publication output, citation impact, and h-index, provide evidence of consistent academic engagement and research influence within the biomedical sciences.[1]
Abstract
This article summarizes the academic profile of Henry Wong in relation to the Innovative Research Award. The profile highlights measurable scholarly indicators, institutional affiliation, and research specialization in biomarkers of response. Bibliometric evidence demonstrates sustained publication activity, scientific visibility, and citation performance, supporting recognition within the international biomedical research community.[1]
Keywords
Innovative Research Award, Henry Wong, Biomarkers of Response, Translational Medicine, Biomedical Research, Clinical Biomarkers, Scopus Author, Research Impact, Citation Analysis, World Life Science Awards.
Introduction
Modern biomedical research increasingly relies on the identification and validation of biomarkers that support disease diagnosis, treatment selection, and therapeutic monitoring. Researchers working in this area contribute to evidence-based clinical decision-making through interdisciplinary collaboration involving laboratory science, clinical investigation, and statistical evaluation. Bibliometric databases such as Scopus provide standardized measures for assessing scholarly productivity and scientific influence.[2]
Research Contributions
Research involving biomarkers of response contributes to improved understanding of disease progression, therapeutic effectiveness, and patient stratification. Publications within this field frequently integrate molecular biology, clinical research, pathology, and statistical analysis to support precision medicine initiatives. Such interdisciplinary work is valuable for developing reproducible diagnostic and prognostic approaches.[3]
Publications
The publication portfolio demonstrates continuous scholarly activity indexed within Scopus. Collectively, the available publications have contributed to citation accumulation and measurable research visibility. Representative biomedical literature in biomarker research commonly includes clinical validation studies, translational investigations, and outcome analyses employing internationally recognized reporting standards.[4]
Research Impact
Bibliometric indicators provide one method of evaluating scientific influence. An h-index of 30 together with more than three thousand citations reflects a publication record that has received sustained scholarly attention.
Award Suitability
Based on the available bibliometric information, Henry Wong demonstrates characteristics commonly considered during academic award evaluations, including sustained publication output, significant citation performance, and specialization within an important biomedical research area.
Conclusion
Henry Wong’s scholarly profile reflects sustained research activity within biomarkers of response, supported by established bibliometric indicators and institutional affiliation. The available evidence illustrates continued participation in biomedical research and provides an appropriate basis for academic recognition within programs such as the World Life Science Awards, subject to the complete evaluation criteria established by the organizing committee.[1]
External Links
References
- Elsevier. (n.d.). Scopus author details: Henry Wong, Author ID 55574188738. Scopus.
https://www.scopus.com/pages/authors/55574188738
- Efficacy and safety of denileukin diftitox-cxdl, an improved purity formulation of denileukin diftitox, in patients with relapsed or refractory cutaneous T-cell lymphoma. Journal of Clinical Oncology, 43(10), 1198–1209.
https://doi.org/10.1200/JCO-24-01549
- Mogamulizumab in combination improves clinical outcomes in relapsed and refractory Sézary syndrome. Frontiers in Hematology, 4, Article 1557641.
https://doi.org/10.3389/frhem.2025.1557641
- World Life Science Awards. (n.d.). Award nomination and evaluation information.
https://lifescienceaward.com/